UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | G | H | J | K | L | M | O | P | R | S | T | V | W
Number of items: 37.

A

ARRIS, CE; BLEASDALE, C; CALVERT, AH; CURTIN, NJ; DALBY, C; GOLDING, BT; GRIFFIN, RJ; (1994) PROBING THE ACTIVE-SITE AND MECHANISM OF ACTION OF O-6-METHYLGUANINE-DNA METHYLTRANSFERASE WITH SUBSTRATE-ANALOGS TO (O-6-SUBSTITUTED GUANINES). ANTI-CANCER DRUG DES , 9 (5) 401 - 408.

B

BAGSHAWE, KD; SHARMA, SK; SPRINGER, CJ; ROGERS, GT; (1994) ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - REVIEW. ANNALS OF ONCOLOGY , 5 (10) pp. 879-891.

BEVERLEY, PCL; SADOVNIKOVA, E; ZHU, X; HICKLING, J; GAO, L; CHAIN, B; COLLINS, S; (1994) STRATEGIES FOR STUDYING MOUSE AND HUMAN IMMUNE-RESPONSES TO HUMAN PAPILLOMAVIRUS TYPE-16. In: Chadwick, DJ and Marsh, J, (eds.) VACCINES AGAINST VIRALLY INDUCED CANCERS. (pp. 78 - 96). JOHN WILEY & SONS LTD

BISSET, GMF; BAVETSIAS, V; THORNTON, TJ; PAWELCZAK, K; CALVERT, AH; HUGHES, LR; JACKMAN, AL; (1994) THE SYNTHESIS AND THYMIDYLATE SYNTHASE INHIBITORY ACTIVITY OF L-GAMMA-L-LINKED DIPEPTIDE AND L-GAMMA-AMIDE ANALOGS OF 2-DESAMINO-2-METHYL-N(10)-PROPARGYL-5,8-DIDEAZAFOLIC ACID (ICI-198583). J MED CHEM , 37 (20) 3294 - 3302.

BLEEHEN, NM; CALVERT, AH; LEE, SM; HARPER, P; KAYE, SB; JUDSON, I; BRAMPTON, M; (1994) A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-II TRIAL OF CB10-277 GIVEN BY 24-HOUR INFUSION FOR MALIGNANT-MELANOMA. BRIT J CANCER , 70 (4) 775 - 777.

BOXER, GM; ABASSI, AM; PEDLEY, RB; BEGENT, RHJ; (1994) LOCALIZATION OF MONOCLONAL-ANTIBODIES REACTING WITH DIFFERENT EPITOPES ON CARCINOEMBRYONIC ANTIGEN (CEA) - IMPLICATIONS FOR TARGETED THERAPY. BRIT J CANCER , 69 (2) 307 - 314.

BRIDGEWATER, JA; SOUHAMI, RL; ALLGROVE, J; KENDALL, B; PRITCHARD, J; (1994) INTRACRANIAL GERM-CELL TUMORS PRESENTING WITH HYPOPITUITARISM - SUCCESSFUL TREATMENT WITH CHEMOTHERAPY ALONE. EUR J CANCER , 30A (9) 1401 - 1403.

C

CALVERT, AH; (1994) DOSE OPTIMIZATION OF CARBOPLATIN IN ADULTS. ANTICANCER RESEARCH , 14 (6A) 2273 - 2277.

CALVERT, AH; LIND, MJ; GHAZALASWAD, S; GUMBRELL, L; MILLWARD, MJ; BAILEY, NP; DOREGREEN, F; (1994) CARBOPLATIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR AS FIRST-LINE TREATMENT FOR EPITHELIAL OVARIAN-CANCER - A PHASE-I DOSE-INTENSITY ESCALATION STUDY. SEMIN ONCOL , 21 (5) 1 - 6.

CHESTER, KA; BEGENT, RHJ; ROBSON, L; KEEP, P; PEDLEY, RB; BODEN, JA; BOXER, G; (1994) PHAGE LIBRARIES FOR GENERATION OF CLINICALLY USEFUL ANTIBODIES. LANCET , 343 (8895) 455 - 456.

CHESTER, KA; ROBSON, L; KEEP, PA; PEDLEY, RB; BODEN, JA; BOXER, GM; HAWKINS, RE; (1994) PRODUCTION AND TUMOR-BINDING CHARACTERIZATION OF A CHIMERIC ANTI-CEA FAB EXPRESSED IN ESCHERICHIA-COLI. INT J CANCER , 57 (1) 67 - 72.

G

GRIMALDI, KA; BINGHAM, JP; SOUHAMI, RL; HARTLEY, JA; (1994) DNA-DAMAGE BY ANTICANCER AGENTS AND ITS REPAIR - MAPPING IN CELLS AT THE SUBGENE LEVEL WITH QUANTITATIVE POLYMERASE CHAIN-REACTION. ANAL BIOCHEM , 222 (1) 236 - 242.

GRIMALDI, KA; MCADAM, SR; SOUHAMI, RL; HARTLEY, JA; (1994) DNA-DAMAGE BY ANTICANCER AGENTS RESOLVED AT THE NUCLEOTIDE LEVEL OF A SINGLE-COPY GENE - EVIDENCE FOR A NOVEL BINDING-SITE FOR CISPLATIN IN CELLS. NUCLEIC ACIDS RES , 22 (12) 2311 - 2317. Gold open access

H

HARTLEY, JA; MCADAM, SR; DAS, S; ROLDAN, MC; HASKELL, MK; LEE, M; (1994) MOLECULAR AND CELLULAR PHARMACOLOGY OF NOVEL PHOTOACTIVE PSORALEN AND COUMARIN CONJUGATES OF PYRROLE-CONTAINING AND IMIDAZOLE-CONTAINING ANALOGS OF NETROPSIN. ANTI-CANCER DRUG DES , 9 (3) 181 - 197.

HARTLEY, JM; HANSEN, L; HARLAND, SJ; NICHOLSON, PW; PASINI, F; SOUHAMI, RL; (1994) METABOLISM OF IFOSFAMIDE DURING A 3 DAY INFUSION. BRIT J CANCER , 69 (5) 931 - 936.

J

Jones, AL; Trott, P; Cunningham, D; Rosin, RD; Coleman, D; Sauven, P; Glazer, G; (1994) A pilot study of intraperitoneal cisplatin in the management of gastric cancer. Ann Oncol , 5 (2) pp. 123-126.

K

KELLY, KM; BEVERLEY, PCL; CHU, AC; DAVENPORT, V; GORDON, I; SMITH, M; PRITCHARD, J; (1994) SUCCESSFUL IN-VIVO IMMUNOLOCALIZATION OF LANGERHANS CELL HISTIOCYTOSIS WITH USE OF A MONOCLONAL-ANTIBODY, NA1/34. J PEDIATR , 125 (5) 717 - 722.

KING, DJ; TURNER, A; FARNSWORTH, APH; ADAIR, JR; OWENS, RJ; PEDLEY, RB; BALDOCK, D; (1994) IMPROVED TUMOR TARGETING WITH CHEMICALLY CROSS-LINKED RECOMBINANT ANTIBODY FRAGMENTS. CANCER RES , 54 (23) 6176 - 6185.

L

LANE, DM; EAGLE, KF; BEGENT, RHJ; HOPESTONE, LD; GREEN, AJ; CASEY, JL; KEEP, PA; (1994) RADIOIMMUNOTHERAPY OF METASTATIC COLORECTAL TUMORS WITH IODINE-131-LABELED ANTIBODY TO CARCINOEMBRYONIC ANTIGEN - PHASE I/II STUDY WITH COMPARATIVE BIODISTRIBUTION OF INTACT AND F(AB')(2) ANTIBODIES. BRIT J CANCER , 70 (3) 521 - 525.

LEE, M; ROLDAN, MC; HASKELL, MK; MCADAM, SR; HARTLEY, JA; (1994) IN-VITRO PHOTOINDUCED CYTOTOXICITY AND DNA-BINDING PROPERTIES OF PSORALEN AND COUMARIN CONJUGATES OF NETROPSIN ANALOGS - DNA SEQUENCE-DIRECTED ALKYLATION AND CROSS-LINK FORMATION. J MED CHEM , 37 (8) 1208 - 1213.

LOFLIN, PT; HOCHHAUSER, D; HICKSON, ID; MORALES, F; ZWELLING, LA; (1994) MOLECULAR ANALYSIS OF A POTENTIALLY PHORBOL-REGULATABLE REGION OF THE HUMAN TOPOISOMERASE II-ALPHA GENE PROMOTER. BIOCHEM BIOPH RES CO , 200 (1) 489 - 496.

M

MARSHALL, D; PEDLEY, RB; BODEN, JA; BODEN, R; BEGENT, RHJ; (1994) CLEARANCE OF CIRCULATING RADIO-ANTIBODIES USING STREPTAVIDIN OR 2ND ANTIBODIES IN A XENOGRAFT MODEL. BRIT J CANCER , 69 (3) 502 - 507.

O

OLABIRAN, Y; LEDERMANN, JA; MARSTON, NJ; BOXER, GM; HICKS, R; SOUHAMI, RL; SPIRO, SG; (1994) THE SELECTION OF ANTIBODIES FOR TARGETED THERAPY OF SMALL-CELL LUNG-CANCER (SCLC) USING A HUMAN TUMOR SPHEROID MODEL TO COMPARE THE UPTAKE OF CLUSTER-1 AND CLUSTER-W4 ANTIBODIES. BRIT J CANCER , 69 (2) 247 - 252.

Ornadel, D; Souhami, RL; Whelan, J; Nooy, M; Ruiz de Elvira, C; Pringle, J; Lewis, I; (1994) Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup. J Clin Oncol , 12 (9) pp. 1842-1848. 10.1200/jco.1994.12.9.1842.

P

PEDLEY, RB; BEGENT, RHJ; BODEN, JA; BOXER, GM; BODEN, R; KEEP, PA; (1994) ENHANCEMENT OF RADIOIMMUNOTHERAPY BY DRUGS MODIFYING TUMOR BLOOD-FLOW IN A COLONIC XENOGRAFT MODEL. INT J CANCER , 57 (6) 830 - 835.

R

Rodriguez-Viciana, P; Warne, PH; Dhand, R; Vanhaesebroeck, B; Gout, I; Fry, MJ; Waterfield, MD; (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature , 370 (6490) pp. 527-532. 10.1038/370527a0.

S

SANGHANI, PC; JACKMAN, A; EVANS, VR; THORNTON, T; HUGHES, L; CALVERT, AH; MORAN, RG; (1994) A STRATEGY FOR THE DESIGN OF MEMBRANE-PERMEABLE FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE INHIBITORS - BAY-REGION-SUBSTITUTED 2-DESAMINO-2-METHYL-5,8-DIDEAZAFOLATE ANALOGS. MOL PHARMACOL , 45 (2) 341 - 351.

SHARMA, SK; BAGSHAWE, KD; BURKE, PJ; BODEN, JA; ROGERS, GT; SPRINGER, CJ; MELTON, RG; (1994) GALACTOSYLATED ANTIBODIES AND ANTIBODY-ENZYME CONJUGATES IN ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY. In: (Proceedings) 9th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. (pp. pp. 1114-1120). WILEY-LISS

SHARMA, SK; BODEN, JA; SPRINGER, CJ; BURKE, PJ; BAGSHAWE, KD; (1994) ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - A 3-PHASE STUDY IN OVARIAN TUMOR XENOGRAFTS. In: (Proceedings) Meeting on Advances in the Applications of Monoclonal Antibodies in Clinical Oncology. (pp. pp. 219-228). HUMANA PRESS INC

SMELLIE, M; KELLAND, LR; THURSTON, DE; SOUHAMI, RL; HARTLEY, JA; (1994) CELLULAR PHARMACOLOGY OF NOVEL C8-LINKED ANTHRAMYCIN-BASED SEQUENCE-SELECTIVE DNA MINOR-GROOVE CROSS-LINKING AGENTS. BRIT J CANCER , 70 (1) 48 - 53.

SPRINGER, CJ; NICULESCUDUVAZ, I; PEDLEY, RB; (1994) NOVEL PRODRUGS OF ALKYLATING-AGENTS DERIVED FROM 2-FLUOROBENZOIC AND 3-FLUOROBENZOIC ACIDS FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY. J MED CHEM , 37 (15) 2361 - 2370.

SPRINGER, CJ; POON, GK; SHARMA, SK; BAGSHAWE, KD; (1994) ANALYSIS OF ANTIBODY-ENZYME CONJUGATE CLEARANCE BY INVESTIGATION OF PRODRUG AND ACTIVE-DRUG IN AN ADEPT CLINICAL-STUDY. In: (Proceedings) Meeting on Advances in the Applications of Monoclonal Antibodies in Clinical Oncology. (pp. pp. 193-207). HUMANA PRESS INC

Stein, RC; Dalgleish, AG; (1994) Immunomodulatory agents: the cytokines. Eur J Cancer , 30A (3) pp. 400-404.

T

TCHILIAN, EZ; BEVERLEY, PCL; YOUNG, BD; WATT, SM; (1994) MOLECULAR-CLONING OF 2 ISOFORMS OF THE MURINE HOMOLOG OF THE MYELOID CD33 ANTIGEN. BLOOD , 83 (11) 3188 - 3198.

TURNER, A; KING, DJ; FARNSWORTH, APH; RHIND, SK; PEDLEY, RB; BODEN, J; BODEN, R; (1994) COMPARATIVE BIODISTRIBUTIONS OF INDIUM-111-LABELED MACROCYCLE CHIMERIC B72.3 ANTIBODY CONJUGATES IN TUMOR-BEARING MICE. BRIT J CANCER , 70 (1) 35 - 41.

V

Vandenabeele, P; Goossens, V; Beyaert, R; Declercq, W; Grooten, J; Vanhaesebroeck, B; Van de Craen, M; (1994) Functional requirement of the two TNF receptors for induction of apoptosis in PC60 cells and the role of mitochondria in TNF-induced cytotoxicity. Circ Shock , 44 (4) pp. 196-200.

W

WYATT, MD; GARBIRAS, BJ; HASKELL, MK; LEE, M; SOUHAMI, RL; HARTLEY, JA; (1994) STRUCTURE-ACTIVITY RELATIONSHIP OF A SERIES OF NITROGEN MUSTARD-CONTAINING AND PYRROLE-CONTAINING MINOR GROOVE-BINDING AGENTS RELATED TO DISTAMYCIN. ANTI-CANCER DRUG DES , 9 (6) 511 - 525.

This list was generated on Sun Dec 4 03:36:18 2016 GMT.